Summary
Updated Aug 30, 2026
Elaine D. Sun is Director of RECURSION PHARMACEUTICALS, INC. (RXRX). 3 SEC Form 4 filings on record going back to 2025, most recently on 22 June 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Elaine D. Sun has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Elaine D. Sun files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Gibson - $3.96M of RXRX open-market activity in the last 12 months
- Blake Borgeson - $3.04M of RXRX open-market activity in the last 12 months
- Najat Khan - $179K of RXRX open-market activity in the last 12 months
- Ben R. Taylor - $68K of RXRX open-market activity in the last 12 months
- Namandje Bumpus - $28K of RXRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Elaine D. Sun?
Elaine D. Sun is a corporate insider, tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Elaine D. Sun submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Elaine D. Sun's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Elaine D. Sun and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
